Lyon wrote:You got that right....GM stocks going for $0??......if things reach that point I'm going to buy 51% of GM!
flipflopper wrote:... These are the results of the phase IIb trial...
MaggieMae wrote:Just read this article on another site. Makes me feel discouraged, sad, angry, etc., etc.
JanethePain wrote:flipflopper wrote:... These are the results of the phase IIb trial...
Hate to nitpick here, guys, but IIb won't be finished until the last one of us completes that second round of Week 52.
Now that preliminary report has been a little disappointing overall, but in my case, "the only thing better than [my results] is a cure." And that's straight from my neuro's mouth, too.
CureOrBust wrote:On Page 5, they say .28 ARR for Tovaxin. On page 6 they say "Tovaxin ARR lowest of any marketed or developed therapy" and again state the ARR at ".28 relapses/patient/year". Yet on page 5, Tysabri is shown as being .22; wouldn't that be lower?
Now, on page 18, the graph shows ARR for Tovaxin at .214. It does not tie into their previously stated .22 value, but then does make sense with their claim of "lowest" ARR.
And then on page 30 they say "Lowest ARR of most marketed drugs".
Am I reading it all wrong?
Users browsing this forum: No registered users